Bone Metastases in Pheochromocytoma

Last Modified: September 23, 2011

Share article


Question

Dear OncoLink "Ask The Experts,"

In metastatic pheo, what is the current thinking about treating/removing tumors and bone lesions as they are identified? My understanding is that the concern with bone lesions is the deterioration of the bone. Can bone lesions also be the cause of further spreading of the disease?

Answer

Giorgos Karakousis, MD, Surgical Oncologist at Penn Medicine, responds:

Generally speaking, treatment of metastatic neuroendocrine tumors, including pheos, involves a multidisciplinary approach of surgeons, medical oncologists, radiation oncologists and interventional radiologists, and the specific approach really depends upon the location of the metastases and the symptoms associated with the metastatic tumor deposits.

David Metz, MD, Gastroenterologist at Penn Medicine, adds:

Bone disease is usually an indication of long-standing disease. Usually this is spread from elsewhere, though theoretically I am sure disease can spread from bone to elsewhere.

This question and answer was part of the OncoLink Brown Bag Chat Series. View the entire Focus on Neuroendocrine Tumors Webchat transcript.



I Wish You Knew

How an oncology social worker can improve your cancer experience

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More